Skip to main content
ARS Home » Midwest Area » Ames, Iowa » National Animal Disease Center » Virus and Prion Research » Research » Publications at this Location » Publication #276237
Title: Influenza A virus in pigs – protection, provocation and predisposition

Author
item Loving, Crystal
item Baker, Amy
item Brockmeier, Susan
item GAUGER, PHILLIP - Iowa State University
item PEREZ, DANIEL - University Of Maryland
item KHURANA, SURENDE - Food And Drug Administration(FDA)
item GOLDING, HANA - Food And Drug Administration(FDA)

Submitted to: Gordon Research Conference Proceedings
Publication Type: Abstract Only
Publication Acceptance Date: 10/13/2011
Publication Date: N/A
Citation: N/A

Interpretive Summary:

Technical Abstract: Endemic strains of influenza A virus (IAV) in North America pigs consist of the subtypes H1N1, H1N2, and H3N2. These circulating strains contain the triple reassortant internal gene (TRIG) cassette resulting from incorporation of genes from swine, avian, and human IAV's. Genetic drift and reassortment have resulted in four H1 phylogenetic clusters and all currently co-circulate in US swine. Inactivated IAV vaccines do not provide adequate protection to heterologous homosubtypic IAV, nor heterosubtypic IAV and may even lead to vaccine associated enhanced respiratory disease (VAERD). In pigs, vaccination with an inactivated H1N2 IAV (MN08) resulted in enhanced disease following challenge with pandemic H1N1 IAV (CA09). Levels of proinflammatory cytokines IL-8, IL-1 and IL-6 in the lungs were significantly increased in the VAERD group, whereas the antiviral cytokine IFNa was significantly decreased in the VAERD group. There was no detectable antibody to the HA1 region of CA09 following vaccination with inactivated MN08, though there was cross-reactive antibody to the HA2 region that could increase infectivity of CA09. Interestingly, this enhancement does not occur following vaccination with a modified-live MN08 IAV. IAV in pigs predisposes to secondary bacterial infection with Haemophilus, regardless of VAERD. With the continued emergence of unique antigenic subtypes the need for an effective IAV vaccine in pigs remains high, and control of bacterial infection and spreading is critical when IAV outbreaks occur.